Patients may have questions when they pick up their prescription of Fiasp®. Here are some things you may want to discuss with them.
Talking to patients about their Fiasp® prescription

Talking to patients about their Fiasp® prescription
Patients may have questions when they pick up their prescription of Fiasp®. Here are some things you may want to discuss with them.

What is Fiasp®?
Fiasp® is a rapid-acting human insulin analog indicated to improve glycemic control in adults and children with diabetes mellitus.

Fiasp® is fast

Onset of appearance of ~2.5 minutes1
Fiasp® is familiar

A formulation of insulin aspart with 2 excipients added1,2

Available in FlexTouch®, PenFill®, and vial
Dose timing is different for Fiasp® vs NovoLog® (insulin aspart injection) 100 U/mL1,3
NovoLog®


Fiasp®


Instruct patients on basal-bolus treatment who forget a mealtime dose to monitor their blood glucose level to decide if an insulin dose is needed, and to resume their usual dosing schedule at the next meal.
See how dosing options can help patients at mealtime
Fiasp® Trade Unit Product Information

Fiasp® and NovoLog® have the same generic name, insulin aspart 100 U/mL, so be sure to confirm the brand name if it isn’t specified on the written script or in the ePrescribing system.
3 mL single-patient use Fiasp® FlexTouch® pen
NDC number
0169-3204-15
Form/strength
100 units/mL
Pens per package
5
Units of insulin per pen
300
Units of insulin per package
1500
Max dose per injection
80
Dose increment
1 unit

10 mL multiple-dose vials
NDC number
0169-3201-11
Form/strength
100 units/mL

PenFill® cartridge
NDC number
0169-3205-15
Form/strength
100 units/mL

See how FlexTouch® works with the Instructions For Use
Fiasp® FlexTouch® Instructions For Use
Show patients the illustrated step-by-step Instructions For Use. Patients can learn more about Fiasp® by viewing this video on MyFiasp.com.
See the features of FlexTouch®, the latest pen technology from Novo Nordisk.
How to store Fiasp® FlexTouch®
How to store Fiasp®
Fiasp® FlexTouch®
Not in use (unopened): If unopened, Fiasp® FlexTouch® should be stored in a refrigerator (36°F to 46°F [2°C to 8°C]) until expiration date. If unopened but improperly stored outside of refrigerated conditions, begin in-use storage for a maximum of 4 weeks.1
In use (opened): After first use, Fiasp® FlexTouch® can be stored at room temperature (below 86°F [30°C]) or in the refrigerator (36°F to 46°F [2°C to 8°C]) without the needle attached for a maximum of 4 weeks (28 days).1
Fiasp® vial
Not in use (unopened): If unopened, Fiasp® vials should be stored in a refrigerator (36°F to 46°F [2°C to 8°C]) until expiration date. If unopened but improperly stored outside of refrigerated conditions, begin in-use storage for a maximum of 4 weeks.1
In use (opened): After first use, Fiasp® vials can be stored at room temperature (below 86°F [30°C]) or in the refrigerator (36°F to 46°F [2°C to 8°C]) for a maximum of 4 weeks (28 days).1
Fiasp® PenFill®
Not in use (unopened): If unopened, Fiasp® PenFill® should be stored in a refrigerator (36°F to 46°F [2°C to 8°C]) until expiration date. If unopened but improperly stored outside of refrigerated conditions, begin in-use storage for a maximum of 4 weeks.1
In use (opened): After first use, Fiasp® PenFill® can be stored at room temperature (below 86°F [30°C]) for a maximum of 4 weeks (28 days).1 Do not refrigerate Fiasp® PenFill® cartridges after first use.

Help patients save
Help patients save
Eligible patients can save on prescriptions of Fiasp® with a Savings Card.
Personalized patient support
Personalized patient support
Cornerstones4Care® is a free support program for patients to help them manage their diabetes.